Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Mallinckrodt's FTC Settlement Seems A Blip For Acthar Blockbuster

Jan 20 2017

• By Mandy Jackson

Compliance

Related Content

Pharma’s Pricing Debate Splinters As US Political Confrontation Looms

Jan 19 2017

Questcor buys Synacthen from Novartis in Acthar defensive move

Jun 12 2013

Mallinckrodt Vision For Growth Emphasizes Acthar, Ofirmev

Oct 20 2014

Retrophin takes on Questcor with ACTH analog, files for IPO

Dec 19 2013

Mallinckrodt pursues core quest with Questcor merger

Apr 07 2014

Mallinckrodt, FTC And The Antitrust Risks Of Pipeline Acquisitions

Jan 20 2017

Questcor regains some ground after Acthar hit but coverage concerns linger

Sep 21 2012

Related Companies

Mallinckrodt plc

Marathon Pharmaceuticals LLC

Novartis AG

Travere Therapeutics, Inc.

Additional Topics

Commercial Companies Compliance Legal Issues Market Access Pricing Debate BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window